Frazier Management LLC’s Iovance Biotherapeutics Inc Position
Does Frazier Management LLC own Iovance Biotherapeutics Inc (IOVA)? Not currently — the last reported position was 1.75M shares worth $33M in Q4 2021; the fund’s latest 13F (Q3 2022) no longer reports it.
Position Value
$33M
Q4 2021
Shares
1.75M
% of Portfolio
+2.57%
Quarters Held
13
position exited
Position History IOVA
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2021 | 1.75M | $33M | +2.57% |
| Q3 2021 | 2.67M | $66M | +5.28% |
| Q2 2021 | 2.14M | $56M | +5.13% |
| Q1 2021 | 1.31M | $42M | +3.33% |
| Q4 2020 | 1.31M | $61M | +4.69% |
| Q3 2020 | 1.31M | $43M | +3.88% |
| Q2 2020 | 1.31M | $36M | +3.16% |
| Q1 2020 | 1.75M | $52M | +5.94% |
| Q4 2019 | 1.75M | $48M | +8.13% |
| Q3 2019 | 1.75M | $32M | +9.96% |
| Q2 2019 | 2.19M | $54M | +13.75% |
| Q1 2019 | 2.19M | $21M | +5.01% |
| Q4 2018 | 2.19M | $19M | +5.00% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Frazier Management LLC’s full portfolio or all institutional holders of IOVA.